New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2013
09:01 EDTSWKS, CRUS, NOK, LOGI, ESI, MLNX, NVAX, XRX, FFIV, TZOO, SWFT, NFLX, AAPLOn The Fly: Pre-market Movers
UP AFTER EARNINGS/GUIDANCE: Netflix (NFLX), up 40%... Swift Transportation (SWFT), up 13.5%... Travelzoo (TZOO), up 7.6%... F5 Networks (FFIV), up 4%... Xerox (XRX), up 3.6%... ALSO HIGHER: Novavax (NVAX), up 7.8% after BARDA decides to continue contracts for both seasonal and pandemic flu programs... DOWN AFTER EARNINGS/GUIDANCE: Apple (AAPL), down 9.9%... Mellanox (MLNX), down 19.6%... ITT Educational (ESI), down 9.2%... Logitech (LOGI), down 8.4%... Nokia (NOK), down 5.8%... ALSO LOWER: Several Apple component suppliers lower after Apple's report, including Cirrus Logic (CRUS), down 6.1% and Skyworks (SWKS), down 5%.
News For AAPL;NFLX;SWFT;TZOO;FFIV;XRX;NVAX;MLNX;ESI;LOGI;NOK;CRUS;SWKS From The Last 14 Days
Check below for free stories on AAPL;NFLX;SWFT;TZOO;FFIV;XRX;NVAX;MLNX;ESI;LOGI;NOK;CRUS;SWKS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | all recent news | >>
September 8, 2014
16:00 EDTNFLX, AAPLOptions Update; September 8, 2014
Subscribe for More Information
13:59 EDTAAPLApple tests support ahead of product announcement
The shares are down less than a percent to $98.20 ahead of Tuesday's expected product announcements. At that price the shares are below the 30-week moving average, but above the 50-week moving average at $96.92. So far there appears little in the way of significant technical damage in spite of recent concerns from the sell-side community. A breakdown tomorrow below the 50-day moving average following the announcements would be cause for greater concern. A move below $95 would break the intermediate-term uptrend on a technical basis. Conversely a move back above the $101 area, near the 10-day moving average, would signal an all-clear on a technical basis for higher prices. The life high for the shares is at $103.74.
13:51 EDTAAPLApple may launch both iPhone models on Sept 19, Apple Insider reports
Apple may launch both iPhone 6 models on September 19, reports Apple Insider. Citing rumors from iGen.fr, the larger 5.5-inch model may not lag behind the 4.7-inch model after all although quantities of the larger version could be limited. Reference Link
11:19 EDTAAPLApple begins sending email alerts when iCloud accounts assessed, MacRumors says
Subscribe for More Information
11:15 EDTAAPLApple to unveil a new product
The product launch will be held on September 9 at 1 pm. Webcast Link
09:56 EDTAAPLGT Advanced risk profile 'neutral at best' into Apple event, says Canaccord
Subscribe for More Information
09:40 EDTNFLX, AAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TWTR TSLA YHOO BAC FB MSFT NFLX GILD MCD
09:29 EDTAAPLCraig-Hallum says Integrated Device likely in Apple iWatch
Subscribe for More Information
09:25 EDTAAPLAlleged leaked images of Apple's iWatch show mic, speaker, Siri, 9to5Mac says
Subscribe for More Information
08:40 EDTAAPLApple volatility increases into September 9 press event
Subscribe for More Information
07:42 EDTNFLXNetflix expands in Europe amid scrutiny, skepticism, WSJ says
Subscribe for More Information
07:35 EDTAAPLAmazon mulls Fire phone UK exclusively deal with O2, FT says
In an effort to rival Apple (AAPL) and Samsung (SSNLF) in the premium smartphone industry, Amazon (AMZN) is in final-stage discussions to sell its new Fire smartphone exclusively through Telefonica’s (TEF) O2 throughout the UK, reported the Financial Times. Reference Link
07:22 EDTAAPLFormer GT Advanced manager points to sapphire covers at Apple, MacRumors says
While neither Apple (AAPL) nor GT Advanced (GTAT) have confirmed that Apple plans to use sapphire covers for its upcoming iPhones, a former product manager at GT claims on his LinkedIn profile that he played a key role in selling Apple on sapphire display covers for its "mobile devices," according to MacRumors, citing a prior report from TechViking. Reference Link
06:44 EDTAAPLApple's iWatch could have own App Store, will run third-party apps, 9to5Mac says
Subscribe for More Information
06:24 EDTAAPLGT Advanced September volatility elevated into Apple event
Subscribe for More Information
06:21 EDTAAPLSmartwatch market to reach $10B by 2018, says Citigroup
Subscribe for More Information
September 7, 2014
20:37 EDTAAPLApple's new iPhones face risk as carriers begin subsidy phase out, WSJ says
Subscribe for More Information
14:10 EDTAAPLApple hires 'renowned' industrial designer Marc Newson, Bloomberg says
Apple has hired "renowned" industrial designer Marc Newson to work on future products, says Bloomberg. Newson will work on the small secretive Apple team that work on designs that give the company's products their physical look and feel, added Bloomberg. Reference Link
13:40 EDTAAPLApple looks to focus on health with unveiling of smartwatch, WSJ says
Subscribe for More Information
12:31 EDTNVAXNovavax presents data on RSV F nanoparticle vaccine induced monoclonal antibody
Novavax presented preclinical data demonstrating that antibodies generated to its RSV F-protein nanoparticle vaccine candidate bind to the site II epitope of the RSV F-protein with a higher affinity than palivizumab, Syangis, at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, ICAAC, in Washington, DC. In poster session 024: I-314b titled "Development and Characterization of Recombinant RSV Nanoparticle Vaccine Induced Monoclonal Antibody.", Novavax used its RSV F vaccine to generate a murine monoclonal antibody, NVX4C6, that binds to the antigenic site II on the RSV F-protein. Using Surface Plasmon Resonance, Novavax was able to compare the binding affinity of NVX4C6 and palivizumab to the antigenic site II. This experiment demonstrated that Novavax' RSV F vaccine can induce antibodies to the antigenic site II that have a higher binding affinity to the site than palivizumab. In addition, NVX4C6 was shown to have a slightly different specificity to the site II epitope and to recognize mutated site II peptide not recognized by palivizumab, suggesting that NVX4C6 may neutralize palivizumab escape mutants.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use